Netherton Syndrome Study Update: New Patients Added; Positive Nine-month ‘Whole Body’ Data
Three additional patients have been added to Quoin Pharmaceuticals Ltd’s investigator-led pediatric Netherton Syndrome study, and a current pediatric patient in the ongoing study shows completely healed skin after nine months of “whole-body” application of QRX003.